The Anthrax Vaccine Program
An Analysis of the CDC's Recommendations for Vaccine Use
Bibliographic Data
| ID | 11040283 |
|---|---|
| Authors | Meryl Nass (Meryl Nass is with Parkview Hospital and Midcoast Hospital, Brunswick, Me, and Maine Medical Center, Portland, Me., corresponding author) |
| Year | 2002 |
| Volume | 92 |
| Issue | 5 |
| Pages | 715-721 |
| Publication date | 2002-05-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | American Journal of Public Health (JOURNAL) |
| Journal identifiers | ISSN: 0090-0036 • E-ISSN: 1541-0048 |
| Publisher | American Public Health Association (PUBLISHER • US) |
| DOI | 10.2105/ajph.92.5.715 |
| PMID | 11988433 |
| OpenAlex | W2054447805 |
| Language | EN |
| Citations received | 4 |
| References cited | 16 |
The anthrax vaccine was never proved to be safe and effective. It is one cause of Gulf War illnesses, and recent vaccinees report symptoms resembling Gulf War illnesses. The vaccine's production has been substandard. Without adequate evaluation, the Food and Drug Administration recently approved (retrospectively) significant changes made to the vaccine's composition since 1990. The vaccine's mandatory use for inhalation anthrax is “off-label.” A skewed review of the vaccine literature by the Centers for Disease Control and Prevention (CDC) led to remunerative collaborative research with the army, involving civilian volunteers. Despite acknowledging possible fetal harm, the CDC offered the vaccine to children and pregnant women. New trends could weaken prelicensure efficacy and safety review of medical products intended for biodefense and avoid manufacturer liability for their use
Anthrax vaccines · Biodefense · Disease control · Environmental health · Family medicine · Food and drug administration · Harm · Immunization · Political science · Vaccination · Bacillus and Francisella bacterial research · Fibromyalgia and Chronic Fatigue Syndrome Research · Health and Conflict Studies · Immunology · Law · Medicine · Virology
| Unique citing works | 4 |
|---|---|
| Citations per year | 0,17 |
| Citation span | 2002 - 2007 (6) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 3 |